drugset
drugset / Trial / NCT00968487

The Safety of Autologous Lyophilized Plasma Versus Fresh Frozen Plasma in Healthy Volunteers

NCT00968487 ↗

Phase 1 Completed 16 enrolled HemCon Medical Technologies, Inc
RandomizedCrossoverSingle-blindTreatment

Summary

A single-site, single-blind study of ascending doses of Lyophilized Plasma in normal healthy volunteers.

Timeline

Start
2010-06
Primary completion
2011-12
Completion
2011-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Fresh Frozen Plasma Protein / enzyme biologic — Other
Subject Lyophilized Plasma Protein / enzyme biologic — Other

Indications

No indication recorded.